CELLCOMPASS
Live / Applied — Fifth extension granted (statement of use) (as of 24 Feb 2026)
What this means for you
Not registered yet, but its 27 Jun 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97476851
- Mark type
- Design + words
- Filed
- 27 Jun 2022
- Published for opposition
- 07 Feb 2023
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 042 — Scientific and technological services: Providing temporary use of on-line non-downloadable software for placing, verifying, tracking, monitoring and fulfilling orders for therapeutic treatments in the field of personalized cell therapy
- Class 044 — Medical, beauty and agricultural services: Providing medical information in the field of personalized cell therapy; providing medical information on immunotherapy
Owner
- Novartis AG, Basel, CH
- Novartis AG, Basel, CH
Prosecution history
- 25 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Feb 2026 — SOU EXTENSION 5 GRANTED
- 30 Sept 2025 — SOU EXTENSION 5 FILED
- 24 Feb 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 01 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 02 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Apr 2025 — SOU EXTENSION 4 GRANTED
- 01 Apr 2025 — SOU EXTENSION 4 FILED
- 01 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 01 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Oct 2024 — SOU EXTENSION 3 GRANTED
- 01 Oct 2024 — SOU EXTENSION 3 FILED
- 01 Oct 2024 — SOU TEAS EXTENSION RECEIVED
- 02 Apr 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Mar 2024 — SOU EXTENSION 2 GRANTED